根據最新的財務報表(Form-10K),Yubo International Biotech Ltd 的總資產為 $0,淨損失為 $0
YBGJ 的關鍵財務比率是什麼?
Yubo International Biotech Ltd 的流動比率為 0,淨利潤率為 0,每股銷售為 $0。
Yubo International Biotech Ltd 的收入按細分市場或地理位置如何劃分?
Yubo International Biotech Ltd 最大收入來源為 Health Management and Health Maintenance Services,在最近的收益報告中收入為 604,676。就地區而言,China 是 Yubo International Biotech Ltd 的主要市場,收入為 604,676。
Yubo International Biotech Ltd 是否盈利?
無,根據最新的財務報表,Yubo International Biotech Ltd 的淨損失為 $0
Yubo International Biotech Ltd 有負債嗎?
無,Yubo International Biotech Ltd 的負債為 0
Yubo International Biotech Ltd 的流通股有多少?
Yubo International Biotech Ltd 的總流通股為 0
關鍵數據
前收市價
$0.0071
開盤價
$0.0071
當日範圍
$0.0071 - $0.0071
52週區間
$0.0071 - $0.1776
交易量
228
平均成交量
4.9K
股息收益率
--
每股盈餘 (TTM)
-0.01
市值
$1.2M
什麼是 YBGJ?
Yubo International Biotech Ltd. engages in the supply of products that process, store, and administer therapeutic doses of endometrial stem cells for the treatment of disease and injuries. The company is headquartered in Beijing, Beijing and currently employs 14 full-time employees. The firm focuses on the research and development and application of endometrial stem cells and offers its products and services under the brand VIVCELL. The Company’s product offerings include healthcare products for respiratory system, skincare products, hair care products, healthy beverages and male and female personal care products. The firm also offers stem cell related services including cell testing and health management consulting services.